327 related articles for article (PubMed ID: 24851682)
1. [Assessment of ovarian reserve with anti-Müllerian hormone in female patients with systemic lupus erythematosus].
Chen D; Yuan S; Zhan Z; Zhan Y; Yang X; Liang L
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(13):977-80. PubMed ID: 24851682
[TBL] [Abstract][Full Text] [Related]
2. Anti-müllerian hormone and ovarian reserve in systemic lupus erythematosus.
Mok CC; Chan PT; To CH
Arthritis Rheum; 2013 Jan; 65(1):206-10. PubMed ID: 23044647
[TBL] [Abstract][Full Text] [Related]
3. Regular menstrual cycles do not rule out ovarian damage in adult women with systemic lupus erythematosus.
Malheiro OB; Rezende CP; Rocha AL; Del Puerto HL; Ferreira GA; Reis FM
Gynecol Endocrinol; 2014 Oct; 30(10):701-4. PubMed ID: 24898133
[TBL] [Abstract][Full Text] [Related]
4. Antimullerian hormone in cases of different reproductive pathologies.
Barbakadze L; Kristasashvili J
Georgian Med News; 2014; (232-233):16-21. PubMed ID: 25214265
[TBL] [Abstract][Full Text] [Related]
5. Ovarian reserve in adult patients with childhood-onset lupus: a possible deleterious effect of methotrexate?
de Araujo DB; Yamakami LY; Aikawa NE; Bonfá E; Viana VS; Pasoto SG; Pereira RM; Serafin PC; Borba EF; Silva CA
Scand J Rheumatol; 2014; 43(6):503-11. PubMed ID: 24881927
[TBL] [Abstract][Full Text] [Related]
6. Brief Report: The Euro-Lupus Low-Dose Intravenous Cyclophosphamide Regimen Does Not Impact the Ovarian Reserve, as Measured by Serum Levels of Anti-Müllerian Hormone.
Tamirou F; Husson SN; Gruson D; Debiève F; Lauwerys BR; Houssiau FA
Arthritis Rheumatol; 2017 Jun; 69(6):1267-1271. PubMed ID: 28235250
[TBL] [Abstract][Full Text] [Related]
7. Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: Influence of the disease severity and therapy on the ovarian reserve.
Di Mario C; Petricca L; Gigante MR; Barini A; Barini A; Varriano V; Paglionico A; Cattani P; Ferraccioli G; Tolusso B; Gremese E
Endocrine; 2019 Feb; 63(2):369-375. PubMed ID: 30324323
[TBL] [Abstract][Full Text] [Related]
8. Assessment of ovarian reserve by serum anti-Müllerian hormone in patients with systemic lupus erythematosus: a meta-analysis.
Luo W; Mao P; Zhang L; Chen X; Yang Z
Ann Palliat Med; 2020 Mar; 9(2):207-215. PubMed ID: 32156138
[TBL] [Abstract][Full Text] [Related]
9. Assessment of anti-Müllerian hormone levels in premenopausal patients with systemic lupus erythematosus.
Gasparin AA; Souza L; Siebert M; Xavier RM; Chakr RM; Palominos PE; Brenol JC; Monticielo OA
Lupus; 2016 Mar; 25(3):227-32. PubMed ID: 26223296
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of ovarian reserve tests in women with systemic lupus erythematosus.
Ulug P; Oner G; Kasap B; Akbas EM; Ozcicek F
Am J Reprod Immunol; 2014 Jul; 72(1):85-8. PubMed ID: 24716861
[TBL] [Abstract][Full Text] [Related]
11. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
[TBL] [Abstract][Full Text] [Related]
12. [Estimation of ovarian response using multiple predictors of ovarian reserve in women undergoing in vitro fertilization-embryo transfer].
He Y; Xia R; Chen X; Ye D; Tang Y; Li P; Niu J; Chen S
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):216-20. PubMed ID: 23443775
[TBL] [Abstract][Full Text] [Related]
13. Subclinical impairment of ovarian reserve in systemic lupus erythematosus patients with normal menstruation not using alkylating therapy.
Ma W; Zhan Z; Liang X; Chen J; Huang X; Liao C
J Womens Health (Larchmt); 2013 Dec; 22(12):1023-7. PubMed ID: 24283710
[TBL] [Abstract][Full Text] [Related]
14. Anti-Müllerian hormone in reproductive age women with systemic lupus erythematosus.
Velarde-Ochoa Mdel C; Esquivel-Valerio JA; Vega-Morales D; Skinner-Taylor CM; Galarza-Delgado DÁ; Garza-Elizondo MA
Reumatol Clin; 2015; 11(2):78-82. PubMed ID: 24815955
[TBL] [Abstract][Full Text] [Related]
15. Ovarian reserve after treatment with alkylating agents during childhood.
Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
[TBL] [Abstract][Full Text] [Related]
16. The effect of serum vitamin D levels on ovarian reserve markers: a prospective cross-sectional study.
Drakopoulos P; van de Vijver A; Schutyser V; Milatovic S; Anckaert E; Schiettecatte J; Blockeel C; Camus M; Tournaye H; Polyzos NP
Hum Reprod; 2017 Jan; 32(1):208-214. PubMed ID: 27927849
[TBL] [Abstract][Full Text] [Related]
17. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
[TBL] [Abstract][Full Text] [Related]
18. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan.
Tremellen K; Zander-Fox D
Aust N Z J Obstet Gynaecol; 2015 Aug; 55(4):384-9. PubMed ID: 26230428
[TBL] [Abstract][Full Text] [Related]
19. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
[TBL] [Abstract][Full Text] [Related]
20. Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: evaluation by using anti-Muellerian hormone.
Lawrenz B; Henes J; Henes M; Neunhoeffer E; Schmalzing M; Fehm T; Kïtter I
Lupus; 2011 Oct; 20(11):1193-7. PubMed ID: 21768179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]